Related Experiment Video
Updated: Mar 26, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Systemic implications of urinary stone disease
Bogdana Kovshilovskaya1, Thomas Chi1, Joe Miller1
1University of California, San Francisco, Department of Urology, 400 Parnassus Ave, 6 Floor Urology Clinics, Box 0638, San Francisco, CA 94143, USA.
Insights
Urinary stone disease is common and costly, linked to metabolic syndrome. A vascular cause may explain the connection between systemic diseases and kidney stones.
Area of Science:
- Nephrology
- Urology
- Metabolic Diseases
Background:
- Urinary stone disease is a prevalent condition with significant morbidity and economic burden.
- It is increasingly associated with systemic conditions like hypertension, diabetes, and metabolic syndrome.
- Existing theories focusing solely on the urinary environment do not fully explain these observed associations.
Purpose of the Study:
- To review evidence linking urinary stone disease with metabolic syndrome components.
- To explore a potential vascular etiology for urinary stone initiation.
Main Methods:
- Literature review of studies examining urinary stones and metabolic syndrome.
- Analysis of existing research on stone formation mechanisms.
- Synthesis of evidence supporting a vascular hypothesis.
Main Results:
- Strong associations exist between urinary stone disease and metabolic syndrome components.
- Systemic diseases may contribute to the rising incidence of urinary stones.
- A vascular pathway is proposed as a unifying mechanism.
Conclusions:
- Urinary stone disease is intricately linked to metabolic syndrome.
- A vascular etiology offers a plausible explanation for the connection between systemic health and stone formation.
- Further research into vascular mechanisms is warranted.
Abstract:
Urinary stone disease is the third most common condition affecting the urinary tract. It contributes to a great deal of morbidity for both men and women, and cost the United States (US) over 5.3 billion dollars in 2000 alone. Moreover, it is associated with systemic diseases such as hypertension, diabetes, and other components of the metabolic syndrome. Reciprocally, these systemic diseases may be contributing to the rising incidence in urinary stone disease. Previously described mechanisms of stone formation attribute stone development and growth to the urinary milieu. While this may partly influence the process, it cannot account for the associations between systemic diseases and stones observed in large community-based studies. Here we present a review of the evidence demonstrating a link between urinary stone disease and components of the metabolic syndrome. We believe a vascular etiology for the initiation of urinary stones may tie these processes together.
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi V: Nursing Management
Nursing Assessment of the Genitourinary System I: Health History

